Effectiveness of Rehabilitation with Technology-Based Systems in Adolescent Idiopathic Scoliosis
Launched by HANDE TUNC · Jun 16, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Adolescent idiopathic scoliosis (AIS) is a three-dimensional structural deformity in growing children, not associated with a cause, in which lateral deviation of the spine over 10° is accompanied by rotation. The magnitude of the Cobb angle is used to classify the severity of scoliosis. In immature AIS cases, if the Cobb angle is between 25°-40°, bracing and exercise therapy is applied. Exercise in AIS is performed to reduce clinical symptoms, improve cosmetics and prevent curve progression. Corrective exercises based on sensorimotor and kinesthetic principles include self-correction in fro...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Being diagnosed with Adolescent Idiopathic Scoliosis,
- • Girls and boys aged between 10-15,
- • Being the Cobb angle between 25-40 degrees,
- • Being using three dimensional brace,
- • Being immature (Risser 0-2 or Sanders 1-4 phase)
- • Regular follow-ups (0-3-6 months)
- Exclusion Criteria:
- • Presence of previous spinal surgery,
- • Progression resulting in the necessity of surgery,
- • Participation in any exercise therapy program,
- • Playing sports at a professional level,
- • Cardiac and respiratory dysfunction and/or concomitant systemic disease,
- • Health (mental, orthopedic) problems that prevent exercise
About Hande Tunc
Hande Tunc is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapies. With a focus on rigorous scientific methodologies and ethical standards, Hande Tunc collaborates with leading research institutions and healthcare professionals to design and conduct clinical trials that address unmet medical needs. The organization emphasizes transparency, patient safety, and data integrity, ensuring that all trials are conducted in compliance with regulatory requirements. Hande Tunc's mission is to contribute to the development of groundbreaking treatments that enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported